Status:
TERMINATED
Sunbit UV Measuring Device to Track Sun Behavior
Lead Sponsor:
University of Zurich
Conditions:
Immunosuppression
Skin Neoplasms
Eligibility:
All Genders
50+ years
Brief Summary
Sunbit is a new wearable UV dosimeter to measure solar radiation in real time. The purpose of this study is to track sun behavior of patients at high risk for skin cancer, to investigate the feasibili...
Detailed Description
A total of 20 patients will be included to wear the Sunbit system during the time of 4 weeks. After this 4 weeks Sunbit will be recollected and data in the form of UV Indices will be extracted and ana...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- History of skin cancer (melanoma or NMSC) or patients with high risk of skin cancer (e.g. immunosuppressive therapy)
- Oral and written informed consent
Exclusion
- Any medical condition that renders the patient bedridden for the duration of 2 weeks
Key Trial Info
Start Date :
August 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT02221843
Start Date
August 1 2014
End Date
March 1 2016
Last Update
July 13 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Dermatology of the University Hospital Zurich
Zurich, Switzerland, 8091